Carbon Biosciences
Carbon Biosciences is a passionate team of drug developers focused on extending the reach of genetic medicines for devastating diseases. They leverage natural viral evolution and recent advances in gene therapy to develop proprietary viral vector libraries with advantages like tissue specificity, larger payloads, and durable treatments, aiming to realize the power of genetic medicines.
Industries
Nr. of Employees
small (1-50)
Carbon Biosciences
Lexington, Massachusetts, United States, North America
Products
Proprietary viral vector library
A curated library of naturally derived viral vectors intended for use as gene delivery vehicles, designed to enable tissue specificity, increased payload capacity, and durable therapeutic strategies.
Proprietary viral vector library
A curated library of naturally derived viral vectors intended for use as gene delivery vehicles, designed to enable tissue specificity, increased payload capacity, and durable therapeutic strategies.
Services
Gene therapy platform R&D
Internal research and development of viral vector platforms and therapeutic candidates for genetic medicines; includes discovery, vector engineering, and preclinical advancement.
Gene therapy platform R&D
Internal research and development of viral vector platforms and therapeutic candidates for genetic medicines; includes discovery, vector engineering, and preclinical advancement.
Expertise Areas
- Gene therapy vector discovery and engineering
- Platform development for genetic medicines
- Preclinical and translational development
- Tropism and payload engineering
Key Technologies
- Viral vector library screening and selection
- Vector tropism engineering
- Payload capacity optimization
- Gene therapy platform architecture